691 results on '"Wood, Erica M."'
Search Results
2. Erratum to: Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes
3. Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies
4. Day-21 bone marrow findings incorrectly designate residual leukaemia in FLT3-mutated acute myeloid leukaemia treated with intensive induction plus midostaurin: a morphology-focused study
5. The 2023 AABB international guidelines for red blood cell transfusions: What is new?
6. Haemovigilance resources available for everyone: A report from the International Haemovigilance Tools Collaborative Project
7. Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies
8. OP95 A Systematic Review Of The Cost And Cost Effectiveness Of Immunoglobulin Treatment In Patients With Hematological Malignancies
9. The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry
10. International Forum on Blood Donation in Individuals with Current, Past or Germline Predisposition to Malignancy: Summary
11. International Forum on Blood Donation in Individuals with Current, Past or Germline Predisposition to Malignancy: Responses
12. Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis
13. Red Blood Cell Transfusion
14. When to use tranexamic acid for the treatment of major bleeding?
15. Monoclonal antibody levels and protection from COVID-19
16. Definitions of massive transfusion in adults with critical bleeding: a systematic review
17. Convalescent plasma for people with COVID-19: a living systematic review
18. Characteristics and Outcomes of Older Patients With Classical Hodgkin Lymphoma: An Australasian Lymphoma Alliance, and Lymphoma and Related Diseases Registry Study
19. Pre‐hospital freeze‐dried plasma for critical bleeding after trauma: A pilot randomized controlled trial
20. Association Between CKD and Major Hemorrhage in Older Persons: Data From the Aspirin in Reducing Events in the Elderly Randomized Trial
21. Haemovigilance: Giving it our best SHOT !
22. Hyperimmune immunoglobulin for people with COVID-19
23. Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis
24. Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry
25. Monoclonal antibody levels and protection from COVID-19
26. The Growth Kinetics of Clonal Hematopoiesis Inform Risk of Blood Cancer Progression
27. Myeloma Treatment Patterns and Clinical Outcomes in the Asia-Pacific: Updated Results from the Asia-Pacific Myeloma and Related Diseases Registry
28. Real World Treatment Outcomes for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant in Different Income Countries within Asia Pacific Region
29. Real World Comparison of Treatment Outcomes for Myeloma in Elderly Transplant-Ineligible Population with RVD, RD and VCD in Frontline Setting: Results from Mrdr Australia and New Zealand
30. Efficacy and Safety of Avatrombopag in Combination with Immunosuppressive Therapy in Treatment-Naïve and Relapsed/Refractory Severe Aplastic Anaemia - the Diaamond-Ava-First and Diaamond-Ava-Next Bayesian Optimal Phase II Trials
31. The Effect of Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Aspirin on Clinical Outcomes in the Healthy Elderly: A Sub-Study of the Aspirin in Reducing Events in the Elderly (ASPREE) Randomized Controlled Trial
32. Characteristics and Outcomes of Elderly Patients with Classical Hodgkin Lymphoma (cHL): An Australian Lymphoma Alliance (ALA), and Lymphoma and Related Disease Registry (LaRDR) Study
33. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study
34. West Nile virus transfusion‐transmission risk in Australia associated with a seasonal outbreak in the United States
35. Postoperative anaemia and patient-centred outcomes after major abdominal surgery: a retrospective cohort study
36. Congenital asplenia study: clinical and laboratory characterisation of adults with congenital asplenia
37. Māori and Pacific Peoples With Multiple Myeloma in New Zealand are Younger and Have Inferior Survival Compared to Other Ethnicities: A Study From the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)
38. Home Delivery: Transfusion Services When and Where They Are Needed
39. SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
40. Blood Transfusion in Hospitals
41. Reply to comment on: Massive transfusion experience, current practice and decision support: A survey of Australian and New Zealand Anaesthetists
42. Cohort Profile: The Shaanxi Blood Donor Cohort in China
43. Whole blood for trauma resuscitation?
44. Determinants of passive antibody efficacy in SARS-CoV-2 infection
45. Realising the potential: leveraging clinical quality registries for real world clinical research
46. The establishment of a multiple myeloma clinical registry in the Asia–Pacific region: The Asia–Pacific Myeloma and Related Diseases Registry (APAC MRDR).
47. Use of platelet transfusions and tranexamic acid in patients with myelodysplastic syndromes: A clinical practice survey.
48. Haemovigilance resources available for everyone: A report from the International Haemovigilance Tools Collaborative Project.
49. Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies.
50. Postnatal Treatment in Fetal and Neonatal Alloimmune Thrombocytopenia: An International Cohort Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.